Elevance Health Inc (ELV)
Days of sales outstanding (DSO)
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Receivables turnover | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| DSO | days | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
December 31, 2024 calculation
DSO = 365 ÷ Receivables turnover
= 365 ÷ —
= —
The days of sales outstanding (DSO) for Elevance Health Inc over the specified time period are not provided in the data. Without the specific DSO figures, it is challenging to provide a detailed analysis of the company's collection efficiency and management of accounts receivable.
DSO is a crucial metric that indicates how long it takes for a company to collect payment after making a sale. A lower DSO is generally favorable as it implies quicker collection of receivables and better liquidity. Conversely, a higher DSO may suggest inefficiencies in collecting payments, potential cash flow issues, or lenient credit policies.
To evaluate Elevance Health Inc's performance effectively, it is essential to have access to the actual DSO values for each quarter. With this information, a comparative analysis could be conducted to assess trends, identify any anomalies, and make informed recommendations to optimize the company's accounts receivable management.
Peer comparison
Dec 31, 2024
See also:
Elevance Health Inc Average Receivable Collection Period (Quarterly Data)